시장보고서
상품코드
1825830

세계의 나노입자 위탁생산 시장 보고서(2025년)

Nanoparticles Contract Manufacturing Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

나노입자 위탁생산 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 12.1%로 57억 9,000만 달러로 성장할 것입니다. 예측 기간의 성장은 약물전달 시스템에 대한 지식 증가, 나노기술 및 재료과학의 발전, 첨단 약물전달 시스템에 대한 수요, 암 치료에서 금속 나노입자에 대한 높은 수요, 제약회사의 급격한 성장에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 업계 리더들 간의 전략적 제휴, 기술 발전, 지속가능하고 친환경적인 나노입자 제조 방법으로의 전환, 식음료 포장에 나노입자의 통합, 기술 통합 등이 있습니다.

향후 5년간 12.1%의 성장률 전망은 지난번 예측보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 스위스에서 조달하는 지질 나노입자 제조 시스템 및 특수 바이오리액터의 비용을 상승시키고, mRNA 치료제 개발을 지연시키거나 바이오 제조 비용을 상승시킴으로써 미국 제약 산업을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

연구 활동에 대한 자원 배분 증가는 나노입자 위탁생산 시장의 확대를 촉진할 태세를 갖추고 있습니다. 연구 투자에는 과학적 지식 향상, 혁신적 기술 개발, 특정 과제 해결을 위한 연구 수행을 위한 재정적 지원이 포함됩니다. 연구 투자 증가에는 기술 혁신에 대한 집중, 사회적 문제에 대한 인식 증가, 신흥 기술에 대한 지원, 지원 정책, 정부의 자금 지원 이니셔티브 등 여러 가지 요인이 기여하고 있습니다. 이러한 투자는 기술 혁신을 촉진하고, 맞춤형을 가능하게 하고, 품질 관리를 보장하고, 확장성을 촉진하고, 학제 간 협력을 촉진하고, 시장 범위를 확장하고, 경제 개발을 촉진함으로써 나노입자의 위탁 제조를 촉진하는 데 도움이되었습니다. 예를 들어, 영국 정부는 2023년 4월 공공 연구개발(R&D) 지출을 대폭 늘려 2024-2025 회계연도까지 220억 파운드(276억 4,000만 달러)의 예산을 책정하고, R&D를 강화하여 국내 혁신을 촉진하겠다는 의지를 밝혔습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 나노입자 위탁생산 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업 분석
  • 세계의 나노입자 위탁생산 시장 : 성장률 분석
  • 세계의 나노입자 위탁생산 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 나노입자 위탁생산 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 나노입자 위탁생산 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 나노입자 위탁생산 시장 나노입자 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 금속 나노입자
  • 지질 나노입자
  • 기타 나노입자
  • 세계의 나노입자 위탁생산 시장 제조 규모별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 상업용
  • 임상
  • 전임상
  • 세계의 나노입자 위탁생산 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 치료제
  • 진단
  • 백신
  • 세계의 나노입자 위탁생산 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 제약회사
  • 바이오테크놀러지 기업
  • 세계의 나노입자 위탁생산 시장 : 하위 세분화 금속 나노입자(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 금 나노입자
  • 은 나노입자
  • 구리 나노입자
  • 철 나노입자
  • 세계의 나노입자 위탁생산 시장 : 하위 세분화 지질 나노입자(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 고체 지질 나노입자(SLN)
  • 나노구조 지질 캐리어(NLC)
  • 지질 코아미셀
  • 세계의 나노입자 위탁생산 시장 : 하위 세분화 기타 나노입자(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 폴리머 나노입자
  • 탄소나노튜브
  • 양자점
  • 덴드리머

제7장 지역별·국가별 분석

  • 세계의 나노입자 위탁생산 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 나노입자 위탁생산 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 나노입자 위탁생산 시장 : 경쟁 구도
  • 나노입자 위탁생산 시장 : 기업 개요
    • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis
    • CordenPharma International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Ajinomoto Bio-Pharma Services Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

  • IBA Worldwide
  • BioVectra Inc.
  • Mevion Medical Systems Inc.
  • Fortis Life Sciences
  • Ascendia Pharmaceuticals LLC
  • LSNE Contract Manufacturing
  • Precision NanoSystems Inc.
  • Ardena Holding NV
  • American Elements
  • Polymun Scientific Immunbiologische Forschung GmbH
  • Danfysik A/S
  • Hitachi Chemical Advanced Therapeutics Solutions LLC
  • Axolabs GmbH
  • AVANSA Technology & Services
  • Cytodiagnostics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

  • 나노입자 위탁생산 시장 2029 : 새로운 기회를 제공하는 국가
  • 나노입자 위탁생산 시장 2029 : 새로운 기회를 제공하는 부문
  • 나노입자 위탁생산 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁 전략

제36장 부록

KSM 25.10.13

Nanoparticle contract manufacturing involves outsourcing the production of nanoparticles to third-party manufacturers or contract manufacturing organizations (CMOs). These services offer a versatile solution for various industries, providing customized nanoparticle formulations and expertise to meet specific application requirements and drive innovation across diverse fields.

The primary types of the nanoparticle contract manufacturing market include metal nanoparticles, lipid nanoparticles, and other nanoparticles. Metal nanoparticles are minute particles of metal typically ranging from 1 to 100 nanometers in size. These nanoparticles are manufactured at various scales, including commercial, clinical, and pre-clinical, for applications such as therapeutics, diagnostics, and vaccines. They are utilized by various end-users, including pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nanoparticles contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides nanoparticles contract manufacturing market statistics, including nanoparticles contract manufacturing industry global market size, regional shares, competitors with a nanoparticles contract manufacturing market share, detailed nanoparticles contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the nanoparticles contract manufacturing industry. This nanoparticles contract manufacturing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nanoparticles contract manufacturing market size has grown rapidly in recent years. It will grow from $3.27 billion in 2024 to $3.67 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to a rising preference for contract manufacturing, increasing need for nanomaterials across various applications, increased usage of therapeutics drug delivery applications, rising demand for nanomedicine, and demand for high-quality nanoparticles.

The nanoparticles contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $5.79 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing knowledge about pharmaceutical delivery systems, advancement in nanotechnology and materials science, demand for advanced drug delivery systems, high demand for metal nanoparticles in cancer therapy, and rapid growth of pharmaceutical companies. Major trends in the forecast period include strategic partnership among industry leaders, technological advancement, the shift towards sustainable and eco-friendly nanoparticle production methods, integration of nanoparticles in food and beverage packaging, and integration of technology.

The forecast of 12.1% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. pharmaceutical industry by increasing the cost of lipid nanoparticle production systems and specialized bioreactors sourced from Germany and Switzerland, thereby delaying mRNA therapeutic development and elevating biomanufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing allocation of resources towards research activities is poised to drive the expansion of the nanoparticle contract manufacturing market. Research investments encompass financial support directed at conducting studies to advance scientific knowledge, develop innovative technologies, and address specific challenges. Several factors contribute to the rise in research investments, including a focus on innovation, heightened awareness of societal issues, backing for emerging technologies, supportive policies, and government funding initiatives. These investments are instrumental in advancing nanoparticle contract manufacturing by fostering technological innovation, enabling customization, ensuring quality control, facilitating scalability, encouraging interdisciplinary collaboration, expanding market reach, and fostering economic development. For example, the UK government announced a substantial increase in public Research and Development (R&D) expenditures in April 2023, with plans to elevate the budget to £22 billion ($27.64 billion) by fiscal year 2024-2025, demonstrating a commitment to enhancing R&D efforts and promoting innovation domestically.

Key players in the nanoparticle contract manufacturing market are leveraging innovative technologies, such as commercial formulation systems, to produce medicines for clinical and commercial purposes and maintain a competitive advantage. Commercial formulation systems provide comprehensive platforms for efficient development and production of nanoparticle-based products. For instance, Cytiva, a US-based provider of life sciences products and solutions, introduced the NanoAssemblr commercial formulation system in July 2023. This system minimizes the risk of cross-contamination, particularly crucial for genomic medicines, by employing a single-use fluid path. It enhances production efficiency by reducing downtime for sanitization and cleaning, enabling the manufacture of multiple lipid nanoparticle products within the same facility. The system features 21 CFR Part 11-compliant software for electronic batch records, real-time monitoring of flow rate, and automated processes such as priming, calibration, formulation, and in-line dilution.

In February 2022, Merck KGaA, a Germany-based technology company, acquired Exelead Inc. for $780 million. This acquisition allows Merck to strengthen its mRNA capabilities and solidify its position as a leading contract development and manufacturing organization in the mRNA vaccine and therapeutic sector. Exelead Inc., a US-based biopharmaceutical company, specializes in lipid nanoparticles (LNP) and complex injectable formulations, with a focus on mRNA therapeutics.

Major companies operating in the nanoparticles contract manufacturing market are AstraZeneca plc, Evonik Industries AG, Emergent BioSolutions Inc., CordenPharma International GmbH, Ajinomoto Bio-Pharma Services, IBA Worldwide, BioVectra Inc., Mevion Medical Systems Inc., Fortis Life Sciences, Ascendia Pharmaceuticals LLC, LSNE Contract Manufacturing, Precision NanoSystems Inc., Ardena Holding NV, American Elements, Polymun Scientific Immunbiologische Forschung GmbH, Danfysik A/S, Hitachi Chemical Advanced Therapeutics Solutions LLC, Axolabs GmbH, AVANSA Technology & Services, Cytodiagnostics Inc., Encapsula NanoSciences LLC, MyBiotech GmbH, Nanochemazone, RiboPro GmbH, TechNano India

North America was the largest region in the nanoparticles contract manufacturing market in 2024. The regions covered in the nanoparticles contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nanoparticles contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanoparticle contract manufacturing market includes revenues earned by entities by providing services such as custom synthesis, scale-up production, and surface modification and functionalization and related drug delivery nanoparticles, diagnostic nanoparticles, cosmetic nanoparticles, and electronic nanoparticles. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanoparticles Contract Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanoparticles contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanoparticles contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanoparticles contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Nanoparticle: Metal Nanoparticles; Lipid Nanoparticles; Other Nanoparticles
  • 2) By Manufacturing Scale: Commercial; Clinical; Pre-Clinical
  • 3) By Application: Therapeutics; Diagnostics; Vaccines
  • 4) By End-User: Pharmaceutical Companies; Biotechnology Companies
  • Subsegments:
  • 1) By Metal Nanoparticles: Gold Nanoparticles; Silver Nanoparticles; Copper Nanoparticles; Iron Nanoparticles
  • 2) By Lipid Nanoparticles: Solid Lipid Nanoparticles (SLNs); Nanostructured Lipid Carriers (NLCs); Lipid-Core Micelles
  • 3) By Other Nanoparticles: Polymeric Nanoparticles; Carbon Nanotubes; Quantum Dots; Dendrimers
  • Companies Mentioned: AstraZeneca plc; Evonik Industries AG; Emergent BioSolutions Inc.; CordenPharma International GmbH; Ajinomoto Bio-Pharma Services; IBA Worldwide; BioVectra Inc.; Mevion Medical Systems Inc.; Fortis Life Sciences; Ascendia Pharmaceuticals LLC; LSNE Contract Manufacturing; Precision NanoSystems Inc.; Ardena Holding NV; American Elements; Polymun Scientific Immunbiologische Forschung GmbH; Danfysik A/S; Hitachi Chemical Advanced Therapeutics Solutions LLC; Axolabs GmbH; AVANSA Technology & Services; Cytodiagnostics Inc.; Encapsula NanoSciences LLC; MyBiotech GmbH; Nanochemazone; RiboPro GmbH; TechNano India
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nanoparticles Contract Manufacturing Market Characteristics

3. Nanoparticles Contract Manufacturing Market Trends And Strategies

4. Nanoparticles Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nanoparticles Contract Manufacturing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Nanoparticles Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Nanoparticles Contract Manufacturing Market Growth Rate Analysis
  • 5.4. Global Nanoparticles Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Nanoparticles Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Nanoparticles Contract Manufacturing Total Addressable Market (TAM)

6. Nanoparticles Contract Manufacturing Market Segmentation

  • 6.1. Global Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metal Nanoparticles
  • Lipid Nanoparticles
  • Other Nanoparticles
  • 6.2. Global Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Commercial
  • Clinical
  • Pre-Clinical
  • 6.3. Global Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutics
  • Diagnostics
  • Vaccines
  • 6.4. Global Nanoparticles Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Companies
  • 6.5. Global Nanoparticles Contract Manufacturing Market, Sub-Segmentation Of Metal Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gold Nanoparticles
  • Silver Nanoparticles
  • Copper Nanoparticles
  • Iron Nanoparticles
  • 6.6. Global Nanoparticles Contract Manufacturing Market, Sub-Segmentation Of Lipid Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Lipid Nanoparticles (SLNs)
  • Nanostructured Lipid Carriers (NLCs)
  • Lipid-Core Micelles
  • 6.7. Global Nanoparticles Contract Manufacturing Market, Sub-Segmentation Of Other Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Nanoparticles
  • Carbon Nanotubes
  • Quantum Dots
  • Dendrimers

7. Nanoparticles Contract Manufacturing Market Regional And Country Analysis

  • 7.1. Global Nanoparticles Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Nanoparticles Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanoparticles Contract Manufacturing Market

  • 8.1. Asia-Pacific Nanoparticles Contract Manufacturing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanoparticles Contract Manufacturing Market

  • 9.1. China Nanoparticles Contract Manufacturing Market Overview
  • 9.2. China Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanoparticles Contract Manufacturing Market

  • 10.1. India Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanoparticles Contract Manufacturing Market

  • 11.1. Japan Nanoparticles Contract Manufacturing Market Overview
  • 11.2. Japan Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanoparticles Contract Manufacturing Market

  • 12.1. Australia Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanoparticles Contract Manufacturing Market

  • 13.1. Indonesia Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanoparticles Contract Manufacturing Market

  • 14.1. South Korea Nanoparticles Contract Manufacturing Market Overview
  • 14.2. South Korea Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanoparticles Contract Manufacturing Market

  • 15.1. Western Europe Nanoparticles Contract Manufacturing Market Overview
  • 15.2. Western Europe Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanoparticles Contract Manufacturing Market

  • 16.1. UK Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanoparticles Contract Manufacturing Market

  • 17.1. Germany Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanoparticles Contract Manufacturing Market

  • 18.1. France Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanoparticles Contract Manufacturing Market

  • 19.1. Italy Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanoparticles Contract Manufacturing Market

  • 20.1. Spain Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanoparticles Contract Manufacturing Market

  • 21.1. Eastern Europe Nanoparticles Contract Manufacturing Market Overview
  • 21.2. Eastern Europe Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanoparticles Contract Manufacturing Market

  • 22.1. Russia Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanoparticles Contract Manufacturing Market

  • 23.1. North America Nanoparticles Contract Manufacturing Market Overview
  • 23.2. North America Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanoparticles Contract Manufacturing Market

  • 24.1. USA Nanoparticles Contract Manufacturing Market Overview
  • 24.2. USA Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanoparticles Contract Manufacturing Market

  • 25.1. Canada Nanoparticles Contract Manufacturing Market Overview
  • 25.2. Canada Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanoparticles Contract Manufacturing Market

  • 26.1. South America Nanoparticles Contract Manufacturing Market Overview
  • 26.2. South America Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanoparticles Contract Manufacturing Market

  • 27.1. Brazil Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanoparticles Contract Manufacturing Market

  • 28.1. Middle East Nanoparticles Contract Manufacturing Market Overview
  • 28.2. Middle East Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanoparticles Contract Manufacturing Market

  • 29.1. Africa Nanoparticles Contract Manufacturing Market Overview
  • 29.2. Africa Nanoparticles Contract Manufacturing Market, Segmentation By Type Of Nanoparticle, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Nanoparticles Contract Manufacturing Market, Segmentation By Manufacturing Scale, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Nanoparticles Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanoparticles Contract Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Nanoparticles Contract Manufacturing Market Competitive Landscape
  • 30.2. Nanoparticles Contract Manufacturing Market Company Profiles
    • 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. CordenPharma International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ajinomoto Bio-Pharma Services Overview, Products and Services, Strategy and Financial Analysis

31. Nanoparticles Contract Manufacturing Market Other Major And Innovative Companies

  • 31.1. IBA Worldwide
  • 31.2. BioVectra Inc.
  • 31.3. Mevion Medical Systems Inc.
  • 31.4. Fortis Life Sciences
  • 31.5. Ascendia Pharmaceuticals LLC
  • 31.6. LSNE Contract Manufacturing
  • 31.7. Precision NanoSystems Inc.
  • 31.8. Ardena Holding NV
  • 31.9. American Elements
  • 31.10. Polymun Scientific Immunbiologische Forschung GmbH
  • 31.11. Danfysik A/S
  • 31.12. Hitachi Chemical Advanced Therapeutics Solutions LLC
  • 31.13. Axolabs GmbH
  • 31.14. AVANSA Technology & Services
  • 31.15. Cytodiagnostics Inc.

32. Global Nanoparticles Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanoparticles Contract Manufacturing Market

34. Recent Developments In The Nanoparticles Contract Manufacturing Market

35. Nanoparticles Contract Manufacturing Market High Potential Countries, Segments and Strategies

  • 35.1 Nanoparticles Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Nanoparticles Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Nanoparticles Contract Manufacturing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제